Patents by Inventor Sean LUND

Sean LUND has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12221641
    Abstract: Provided herein are compositions and methods for improved production of steviol glycosides in a host cell. In some embodiments, the host cell is genetically modified to comprise a heterologous nucleotide sequence encoding a Stevia rebaudiana kaurenoic acid hydroxylase. In some embodiments, the host cell further comprises one or more heterologous nucleotide sequence encoding further enzymes of a pathway capable of producing one or more steviol glycosides in the host cell. The compositions and methods described herein provide an efficient route for the heterologous production of steviol glycosides, including but not limited to, rebaudioside D and rebaudioside M.
    Type: Grant
    Filed: October 14, 2019
    Date of Patent: February 11, 2025
    Assignee: AMYRIS, INC.
    Inventors: Gale A. Wichmann, Wenzong Li, Sean Lund, Shaina J. Jackson, Chantal V. Garcia De Gonzalo, Hailley Warbington, Yi Xiong, Svetlana Alekseyevna Borisova
  • Patent number: 12065685
    Abstract: Provided herein are genetically modified host cells, compositions, and methods for improved production of steviol glycosides. The host cells are genetically modified to contain a heterologous nucleic acid that expresses novel and optimized variants of UGT76G1. The host cell further contains one or more heterologous nucleotide sequence encoding further enzymes of a pathway capable of producing one or more steviol glycosides in the host cell. The host cells, compositions, and methods described herein provide an efficient route for the heterologous production of rebaudioside M.
    Type: Grant
    Filed: September 14, 2023
    Date of Patent: August 20, 2024
    Assignee: AMYRIS, INC.
    Inventors: Sean Lund, Gale Wichmann
  • Publication number: 20220282228
    Abstract: Provided herein are genetically modified host cells, compositions, and methods for improved production of steviol glycosides. The host cells are genetically modified to contain a heterologous nucleic acid that expresses novel and optimized variants of Ro.KAH. The host cell further contains one or more heterologous nucleotide sequence encoding further enzymes of a pathway capable of producing one or more steviol glycosides in the host cell. The host cells, compositions, and methods described herein provide an efficient route for the heterologous production of steviol glycosides including rebaudioside A, rebaudioside D, and rebaudioside M.
    Type: Application
    Filed: May 1, 2020
    Publication date: September 8, 2022
    Inventors: Andrew P. KLEIN, Sean LUND, Gale WICHMANN, Irina KORYAKINA, Kyle HOGAN, Svetlana BORISOVA
  • Publication number: 20220162188
    Abstract: Disclosed are methods for preparing isoprenoid subunits, as well as methods of employing these isoprenoid subunits for the synthesis of isoprenoids. Also provided are isoprenoids prepared using the methods described herein.
    Type: Application
    Filed: January 15, 2020
    Publication date: May 26, 2022
    Inventors: Gavin WILLIAMS, Sean LUND, Rachael HALL
  • Publication number: 20220106619
    Abstract: Provided herein are genetically modified host cells, compositions, and methods for improved production of steviol glycosides. In some embodiments, the host cell is genetically modified to comprise a heterologous nucleic acid expression cassette that expresses an ABC-transporter capable of transporting steviol glycosides to the extracellular space or to the luminal space of an intracellular organelle. In some embodiments, the host cell further comprises one or more heterologous nucleotide sequence encoding further enzymes of a pathway capable of producing one or more steviol glycosides in the host cell. The host cells, compositions, and methods described herein provide an efficient route for the heterologous production of steviol glycosides, including but not limited to, rebaudioside D and rebaudioside M.
    Type: Application
    Filed: January 23, 2020
    Publication date: April 7, 2022
    Inventors: Gale A. WICHMANN, Sean LUND, Joshua LERMAN, Hanxiao JIANG, Yi XIONG
  • Publication number: 20210371892
    Abstract: Provided herein are compositions and methods for improved production of steviol glycosides in a host cell. In some embodiments, the host cell is genetically modified to comprise a heterologous nucleotide sequence encoding a Stevia rebaudiana kaurenoic acid hydroxylase. In some embodiments, the host cell further comprises one or more heterologous nucleotide sequence encoding further enzymes of a pathway capable of producing one or more steviol glycosides in the host cell. The compositions and methods described herein provide an efficient route for the heterologous production of steviol glycosides, including but not limited to, rebaudioside D and rebaudioside M.
    Type: Application
    Filed: October 14, 2019
    Publication date: December 2, 2021
    Inventors: Gale A. WICHMANN, Wenzong LI, Sean LUND, Shaina J. JACKSON, Chantal V. GARCIA DE GONZALO, Hailley WARBINGTON, Yi XIONG, Svetlana Alekseyevna BORISOVA